Impax Laboratories Inc (IPXL) Bucks Bearish Expectations

Impax Laboratories Inc (IPXL) plans to cut over 200 workers as part of its restructuring plan

by Alex Eppstein

Published on Mar 9, 2016 at 2:56 PM

Unlike one sector peer, Impax Laboratories Inc (NASDAQ:IPXL) is on a tear today, after the drugmaker's board of directors approved a restructuring plan. Expected to achieve an annualized cost savings of up to $27 million starting in 2017, the plan will include a workforce reduction upwards of 200 positions.

As alluded to, IPXL has put in a strong showing today, with the drug stock last seen 4.5% higher at $33.99. Historically speaking, this is unusual. The shares have surrendered more than one-fifth of their value in 2016, and late last month hit an annual low of $29.66.

Therefore, it comes as little surprise that Wall Street is in IPXL's bearish corner. In terms of options, short-term traders have gravitated toward puts relative to calls, as evidenced by the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.92 -- ranking in the 71st annual percentile.

Likewise, analysts and short sellers have taken a glass-half-empty approach. While short interest has decreased in recent reporting periods, nearly 12% of IPXL's float remains sold short. At the stock's typical trading levels, it would take over two weeks to cover these bearish bets.

Also, seven of nine analysts tracking Impax Laboratories Inc (NASDAQ:IPXL) have doled out a "hold" or worse rating. About the only sign of optimism among the brokerage crowd is the stock's average 12-month price target of $41.46, which stands at a nearly 23% premium to its current perch.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
Google Postpones Android Reveal, "Now is Not the Time to Celebrate"
"Now is not the time to celebrate," Google said in a message on its website
ZNGA Zooms to 8-Year High on Billion-Dollar Deal
ZNGA is planning to buy Peak for $1.8 billion
Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....